Gynesonics Announces New York Medicaid Coverage for CPT Code 58580, Transcervical Radio Frequency Ablation of Uterine Fibroids
17. Dezember 2024 09:00 ET
|
Gynesonics
REDWOOD CITY, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Gynesonics Inc., a medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is...
Specialdocs Launches Concierge OB/GYN Practice with Prominent NoVA Physicians
11. September 2024 20:00 ET
|
Specialdocs Consultants
Chicago, IL, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Working with Specialdocs Consultants, a pioneer in concierge medicine practice conversions and management, highly respected OB/GYN physicians Manisha...
Gynesonics® Reaches Milestone with 10,000th Patient Treatment with Sonata System
20. August 2024 10:30 ET
|
Gynesonics
REDWOOD CITY, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for...
National Poll Shows Women Are Missing Out on Vacations, Work, and Social Events Due to Gynecological Conditions
02. Mai 2024 10:00 ET
|
LevLane
PHILADELPHIA, May 02, 2024 (GLOBE NEWSWIRE) -- LevLane Advertising, one of Philadelphia's oldest independent full-service advertising agencies, today released the findings of a women's health survey...
Gynesonics Announces Key Executive Appointments to Further Accelerate and Expand Adoption of the Sonata Treatment
19. März 2024 10:00 ET
|
Gynesonics
Gynesonics announces key executive appointments to further accelerate and expand adoption of the Sonata Treatment.
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
02. Januar 2024 11:13 ET
|
Gynesonics
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
02. November 2023 09:41 ET
|
Gynesonics
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
adyn Launches First Test Designed to Prevent Birth Control Side Effects
23. Mai 2022 13:00 ET
|
Adyn, Inc.
SEATTLE, May 23, 2022 (GLOBE NEWSWIRE) -- adyn, the first to create a test designed to prevent birth control side effects, announced today the official launch of its flagship product, The Birth...
Fogarty Innovation Graduate Raydiant Oximetry Raises $5 Million in Oversubscribed Series A2 Financing Round to Support Clinical Study
02. November 2021 12:00 ET
|
Fogarty Innovation
MOUNTAIN VIEW, Calif. and SAN RAMON, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Fogarty Innovation, a nonprofit educational incubator for medical technology companies, announced today that its...
Evofem, Inc. Appoints Louis Villalba as Chief Business Officer
20. Februar 2015 09:10 ET
|
Evofem
SAN DIEGO, Feb. 20, 2015 (GLOBE NEWSWIRE) -- Evofem, Inc. announces that Louis Villalba has been named Chief Business Officer (CBO), effective immediately. Mr. Villalba comes to Evofem with years of...